A detailed history of Crossmark Global Holdings, Inc. transactions in Staar Surgical CO stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 11,016 shares of STAA stock, worth $266,697. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,016
Holding current value
$266,697
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$29.97 - $47.42 $330,149 - $522,378
11,016 New
11,016 $409,000
Q1 2024

May 13, 2024

BUY
$27.67 - $39.61 $231,127 - $330,862
8,353 New
8,353 $319,000
Q2 2023

Jul 31, 2023

BUY
$50.45 - $72.82 $2,320 - $3,349
46 Added 0.69%
6,751 $373,000
Q1 2023

May 12, 2023

SELL
$51.25 - $79.34 $2,767 - $4,284
-54 Reduced 0.8%
6,705 $429,000
Q4 2022

Jan 19, 2023

BUY
$46.82 - $76.2 $24,767 - $40,309
529 Added 8.49%
6,759 $329,000
Q3 2022

Nov 01, 2022

SELL
$70.55 - $111.58 $11,993 - $18,968
-170 Reduced 2.66%
6,230 $440,000
Q2 2022

Jul 29, 2022

BUY
$50.24 - $80.48 $106,508 - $170,617
2,120 Added 49.53%
6,400 $454,000
Q1 2022

May 11, 2022

BUY
$57.98 - $93.5 $2,319 - $3,740
40 Added 0.94%
4,280 $342,000
Q4 2021

Jan 10, 2022

SELL
$88.02 - $127.79 $489,391 - $710,512
-5,560 Reduced 56.73%
4,240 $387,000
Q3 2021

Oct 21, 2021

BUY
$122.75 - $162.68 $1.2 Million - $1.59 Million
9,800 New
9,800 $1.26 Million
Q3 2021

Oct 13, 2021

SELL
$122.75 - $162.68 $1.25 Million - $1.66 Million
-10,180 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$105.76 - $154.96 $38,073 - $55,785
-360 Reduced 3.42%
10,180 $1.55 Million
Q1 2021

Apr 15, 2021

BUY
$78.5 - $126.48 $827,390 - $1.33 Million
10,540 New
10,540 $1.11 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.16B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.